List of Tables
Table 1. Global Vasoactive Intestinal Peptide Tumor Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vasoactive Intestinal Peptide Tumor Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vasoactive Intestinal Peptide Tumor Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vasoactive Intestinal Peptide Tumor Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vasoactive Intestinal Peptide Tumor Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vasoactive Intestinal Peptide Tumor Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vasoactive Intestinal Peptide Tumor Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Vasoactive Intestinal Peptide Tumor Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vasoactive Intestinal Peptide Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasoactive Intestinal Peptide Tumor Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vasoactive Intestinal Peptide Tumor Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vasoactive Intestinal Peptide Tumor Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Vasoactive Intestinal Peptide Tumor Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Vasoactive Intestinal Peptide Tumor Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Vasoactive Intestinal Peptide Tumor Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Vasoactive Intestinal Peptide Tumor Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Vasoactive Intestinal Peptide Tumor Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. Mylan NV Company Information
Table 71. Mylan NV Description and Business Overview
Table 72. Mylan NV Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Mylan NV Vasoactive Intestinal Peptide Tumor Treatment Product
Table 74. Mylan NV Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Ltd Company Information
Table 76. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 77. Teva Pharmaceutical Industries Ltd Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Pharmaceutical Industries Ltd Vasoactive Intestinal Peptide Tumor Treatment Product
Table 79. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Vasoactive Intestinal Peptide Tumor Treatment Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Pfizer Inc. Company Information
Table 86. Pfizer Inc. Description and Business Overview
Table 87. Pfizer Inc. Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Inc. Vasoactive Intestinal Peptide Tumor Treatment Product
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. Novartis AG Company Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis AG Vasoactive Intestinal Peptide Tumor Treatment Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Bayer AG Company Information
Table 96. Bayer AG Description and Business Overview
Table 97. Bayer AG Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bayer AG Vasoactive Intestinal Peptide Tumor Treatment Product
Table 99. Bayer AG Recent Developments/Updates
Table 100. Eli Lilly and Company Company Information
Table 101. Eli Lilly and Company Description and Business Overview
Table 102. Eli Lilly and Company Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Eli Lilly and Company Vasoactive Intestinal Peptide Tumor Treatment Product
Table 104. Eli Lilly and Company Recent Developments/Updates
Table 105. Merck & Co ., Inc Company Information
Table 106. Merck & Co ., Inc Description and Business Overview
Table 107. Merck & Co ., Inc Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Merck & Co ., Inc Vasoactive Intestinal Peptide Tumor Treatment Product
Table 109. Merck & Co ., Inc Recent Developments/Updates
Table 110. Abbott Company Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Abbott Vasoactive Intestinal Peptide Tumor Treatment Product
Table 114. Abbott Recent Developments/Updates
Table 115. AbbVie Inc Company Information
Table 116. AbbVie Inc Description and Business Overview
Table 117. AbbVie Inc Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AbbVie Inc Vasoactive Intestinal Peptide Tumor Treatment Product
Table 119. AbbVie Inc Recent Developments/Updates
Table 120. Merck KGaA Company Information
Table 121. Merck KGaA Description and Business Overview
Table 122. Merck KGaA Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Merck KGaA Vasoactive Intestinal Peptide Tumor Treatment Product
Table 124. Merck KGaA Recent Developments/Updates
Table 125. Sun Pharmaceutical Industries Ltd Company Information
Table 126. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 127. Sun Pharmaceutical Industries Ltd Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sun Pharmaceutical Industries Ltd Vasoactive Intestinal Peptide Tumor Treatment Product
Table 129. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 130. Aurobindo Pharma Company Information
Table 131. Aurobindo Pharma Description and Business Overview
Table 132. Aurobindo Pharma Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Aurobindo Pharma Vasoactive Intestinal Peptide Tumor Treatment Product
Table 134. Aurobindo Pharma Recent Developments/Updates
Table 135. Lupin Company Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Lupin Vasoactive Intestinal Peptide Tumor Treatment Product
Table 139. Lupin Recent Developments/Updates
Table 140. Hikma Pharmaceuticals PLC Company Information
Table 141. Hikma Pharmaceuticals PLC Description and Business Overview
Table 142. Hikma Pharmaceuticals PLC Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Hikma Pharmaceuticals PLC Vasoactive Intestinal Peptide Tumor Treatment Product
Table 144. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 145. Ipsen Pharma Company Information
Table 146. Ipsen Pharma Description and Business Overview
Table 147. Ipsen Pharma Vasoactive Intestinal Peptide Tumor Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Ipsen Pharma Vasoactive Intestinal Peptide Tumor Treatment Product
Table 149. Ipsen Pharma Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Vasoactive Intestinal Peptide Tumor Treatment Distributors List
Table 153. Vasoactive Intestinal Peptide Tumor Treatment Customers List
Table 154. Vasoactive Intestinal Peptide Tumor Treatment Market Trends
Table 155. Vasoactive Intestinal Peptide Tumor Treatment Market Drivers
Table 156. Vasoactive Intestinal Peptide Tumor Treatment Market Challenges
Table 157. Vasoactive Intestinal Peptide Tumor Treatment Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vasoactive Intestinal Peptide Tumor Treatment
Figure 2. Global Vasoactive Intestinal Peptide Tumor Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vasoactive Intestinal Peptide Tumor Treatment Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Global Vasoactive Intestinal Peptide Tumor Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Vasoactive Intestinal Peptide Tumor Treatment Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Specialist Clinic
Figure 10. Other
Figure 11. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vasoactive Intestinal Peptide Tumor Treatment Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vasoactive Intestinal Peptide Tumor Treatment Sales (2020-2031) & (K Units)
Figure 14. Global Vasoactive Intestinal Peptide Tumor Treatment Average Price (US$/Unit) & (2020-2031)
Figure 15. Vasoactive Intestinal Peptide Tumor Treatment Report Years Considered
Figure 16. Vasoactive Intestinal Peptide Tumor Treatment Sales Share by Manufacturers in 2024
Figure 17. Global Vasoactive Intestinal Peptide Tumor Treatment Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Vasoactive Intestinal Peptide Tumor Treatment Players: Market Share by Revenue in Vasoactive Intestinal Peptide Tumor Treatment in 2024
Figure 19. Vasoactive Intestinal Peptide Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Vasoactive Intestinal Peptide Tumor Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Country (2020-2031)
Figure 22. North America Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Country (2020-2031)
Figure 23. United States Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Country (2020-2031)
Figure 26. Europe Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Country (2020-2031)
Figure 27. Germany Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Region (2020-2031)
Figure 34. China Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Country (2020-2031)
Figure 42. Latin America Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Vasoactive Intestinal Peptide Tumor Treatment Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Vasoactive Intestinal Peptide Tumor Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Vasoactive Intestinal Peptide Tumor Treatment by Type (2020-2031)
Figure 52. Global Revenue Market Share of Vasoactive Intestinal Peptide Tumor Treatment by Type (2020-2031)
Figure 53. Global Vasoactive Intestinal Peptide Tumor Treatment Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Vasoactive Intestinal Peptide Tumor Treatment by Application (2020-2031)
Figure 55. Global Revenue Market Share of Vasoactive Intestinal Peptide Tumor Treatment by Application (2020-2031)
Figure 56. Global Vasoactive Intestinal Peptide Tumor Treatment Price (US$/Unit) by Application (2020-2031)
Figure 57. Vasoactive Intestinal Peptide Tumor Treatment Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
